Alex Langford explores the emerging findings from a recent meta-analysis looking at the efficacy and safety of antidepressants added to antipsychotics for people with schizophrenia and schizophrenia-like psychosis.
[read the full story...]
Alex Langford explores the emerging findings from a recent meta-analysis looking at the efficacy and safety of antidepressants added to antipsychotics for people with schizophrenia and schizophrenia-like psychosis.
[read the full story...]
Paul Christiansen presents the results of the EAGLES RCT into the neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patches in smokers with and without psychiatric disorders.
[read the full story...]
Carla McEnery publishes her debut Mental Elf blog on a recent systematic review, which looks at the effect of psychotherapies on positive affect and negative affect in depression.
[read the full story...]
Alastair Canaway summarises a trial of the clinical and cost-effectiveness of internet-based problem-solving guided self-help intervention, in comparison with enhanced usual care, for outpatients on a waiting list for face-to-face treatment for major depression.
[read the full story...]
Murtada Alsaif summarises a recent 4-week long phase II randomised controlled trial of ITI-007 for the treatment of schizophrenia, which contains some positive results for this novel intervention.
[read the full story...]
Chris Pell reviews a recent US survey of young adults, which suggests that social media use was significantly associated with increased depression.
[read the full story...]
Suzanne Dash reviews a cross-sectional study of the prevalence and treatment of common mental disorders in the English national population, which inspires her to host a mental health epidemiology quiz. Fingers on buzzers…
[read the full story...]
Emily Stapley presents the findings of a trial which looks at the effectiveness of an integrated telehealth service for patients with depression.
[read the full story...]
Caroline Struthers summarises a recent population study that explores 10-year trajectories of depressive symptoms and subsequent risk of dementia.
[read the full story...]
Our #EvidenceLive team of bloggers report on a recent feasibility study of psilocybin for the treatment of refractory depression.
[read the full story...]